Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance

Despite improved outcomes in multiple myeloma (MM), a cure remains elusive. However, even before the current therapeutic era, 5% of patients survived >10 years and we propose that immune factors contribute to this longer survival. We identified patients attending our clinic, who had survived >...

Descripción completa

Detalles Bibliográficos
Autores principales: Bryant, C, Suen, H, Brown, R, Yang, S, Favaloro, J, Aklilu, E, Gibson, J, Ho, P J, Iland, H, Fromm, P, Woodland, N, Nassif, N, Hart, D, Joshua, D E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789202/
https://www.ncbi.nlm.nih.gov/pubmed/24036947
http://dx.doi.org/10.1038/bcj.2013.34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789202/
https://www.ncbi.nlm.nih.gov/pubmed/24036947
http://dx.doi.org/10.1038/bcj.2013.34

Ejemplares similares